BioNTech SE is 10.5x more valuable than BIOCRYST PHARMACEUTICALS INC by market capitalization ($21.79 B vs $2.08 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BCRX | BNTX |
|---|---|---|
| Market cap | $2.08 B | $21.79 B |
| US-listed rank | #2072 | #587 |
| Revenue (latest FY) | $25.19M | - |
| Net income (latest FY) | $263.86M | - |
| Net margin | 1047.6% | - |
| P/E (trailing FY) | 7.9 | - |
| SEC filings | 1,935 | 548 |
BioNTech SE is 10.5x more valuable than BIOCRYST PHARMACEUTICALS INC by market capitalization ($21.79 B vs $2.08 B).
Full pages: BIOCRYST PHARMACEUTICALS INC and BioNTech SE, or browse the full rankings.